Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB3653

Introduced
1/24/24  

Caption

Resources To Prevent Youth Vaping Act

Impact

The bill's impact on state laws is significant, as it can shift the financial burden of monitoring and regulating tobacco products towards manufacturers. This may lead to increased compliance costs for the tobacco industry, which could influence their pricing strategies. Moreover, by increasing the funds allocated to the FDA for enforcement and public health campaigns, the bill could strengthen efforts to reduce youth access to tobacco products, including e-cigarettes. Supporters of the bill argue that it will provide the necessary resources to combat the rising rates of vaping among adolescents, while opponents may express concerns over the financial implications for manufacturers and the efficacy of the proposed regulatory measures.

Summary

Senate Bill 3653, known as the Resources To Prevent Youth Vaping Act, aims to implement user fees for tobacco products to support regulatory and public health initiatives aimed at curtailing youth vaping. It seeks to amend the Federal Food, Drug, and Cosmetic Act to clarify the assessment of user fees across all classes of tobacco products, thus enhancing the government's ability to regulate these products effectively. The bill notably includes provisions for increasing user fees over the next few years and establishing a financial framework for future assessments, which stem from sales data collected from manufacturers and importers.

Contention

Notable points of contention surrounding SB3653 include debates over the adequacy of funding for public education campaigns on the dangers of vaping and the effectiveness of regulatory mechanisms to deter youth from using these products. Some legislators may argue that simply increasing user fees does not guarantee a reduction in youth vaping rates without corresponding educational efforts and community engagement. Additionally, discussions may arise regarding how these user fees will be distributed and whether they will effectively meet the needs of local health departments and prevention programs.

Companion Bills

No companion bills found.

Similar Bills

US SB5459

A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

US HB10238

Medical Innovation Act of 2024

US SB5339

Medical Innovation Act of 2024

US SB5027

ROAD to Housing Act Renewing Opportunity in the American Dream to Housing Act

US HB9990

ROAD to Housing Act Renewing Opportunity in the American Dream to Housing Act

US SB4728

Baby Food Safety Act of 2024

US HB9105

Baby Food Safety Act of 2024

US HB9425

Tobacco User Fee Modernization Act of 2024